Nuwellis Inc (NUWE) Stock Price, Quote & News

Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; a...

Industry: Medical Devices

Sector: Healthcare

Phone: 952 345 4200

Website: www.nuwellis.com

Address:

12988 Valley View Road, Eden Prairie, United States

bazooka007 May. 13 at 7:01 AM

$NUWE a so/so q1 er. Still confident in their portfolio. We will see.

0 · Reply

ImfatTrader16 May. 12 at 11:39 PM

$NUWE Damn, the people at this company are either greedy, or overly impressed by any traction and pay out at a level representing that i don’t believe they are running any clinical trials, yet nearly $2 miillion in expense increases are tied up in salaries and sales bonuses. Ho Lee Phuc. they sold 15 consoles ( not 500) in the quater and their rep count is in the teens. why are bonuses and salaries so high? ridiculous Operating expenses for the first quarter of 2026 were approximately $6 million, compared to approximately $4.1 million in the prior year quarter. The increase was driven by higher sales headcount and compensation associated with increased sales activity.

0 · Reply

Felixii May. 12 at 8:08 PM

$NUWE

0 · Reply

done84 May. 12 at 5:10 PM

$NUWE Dilutiom machine. Out of cash again. Scam company. Rot in hell! 🖕🖕

0 · Reply

bazooka007 May. 12 at 1:53 PM

$NUWE please not too much price action

0 · Reply

Dominicstocks May. 12 at 1:38 PM

$NUWE

0 · Reply

EarningsInsider May. 12 at 1:30 PM

https://www.marketbeat.com/earnings/reports/2026-5-12-nuwellis-inc-stock/ $NUWE Nuwellis Earnings Transcript

0 · Reply

StocktwitsEarnings May. 12 at 1:22 PM

$NUWE Q1 '26 Earnings Results & Recap Nuwellis reported Q1 2026 net sales of $2.4M, a 26% increase year-over-year, with gross margin improving to 70.1%. However, Nuwellis also incurred a net loss attributable to common shareholders of approximately $4.3M.

0 · Reply

The_Gambl3r May. 12 at 1:00 PM

$NUWE ..

0 · Reply

done84 May. 12 at 9:56 AM

$NUWE Scam 🖕🖕

0 · Reply

Nuwellis Earnings Call Transcript: Q1 2026

May 12, 2026, 8:00 AM EDT - 1 day ago

Nuwellis, Inc. Announces First Quarter 2026 Financial Results

May 5, 2026, 8:00 AM EDT - 8 days ago

Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026

Apr 29, 2026, 8:30 AM EDT - 13 days ago

Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting

2026-04-28T13:19:54.000Z - 14 days ago

Nuwellis gets notice of allowance from USPTO for lumen midline catheter

Apr 28, 2026, 8:30 AM EDT - 14 days ago

Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology

Apr 23, 2026, 8:30 AM EDT - 19 days ago

Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat

Apr 21, 2026, 8:30 AM EDT - 21 days ago

Nuwellis Announces Aquadex Software Update

2026-04-16T12:51:56.000Z - 26 days ago

Nuwellis announces return of three former team members

Apr 16, 2026, 8:30 AM EDT - 26 days ago

Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum

Apr 9, 2026, 8:30 AM EDT - 4 weeks ago

Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services

2026-04-07T13:45:21.000Z - 5 weeks ago

Nuwellis expands commercial footprint with new South Texas territory

Apr 7, 2026, 8:30 AM EDT - 5 weeks ago

Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory

Mar 31, 2026, 8:30 AM EDT - 6 weeks ago

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

2026-03-17T12:27:39.000Z - 2 months ago

Nuwellis completes acquisition of Rendiatech

Mar 17, 2026, 8:00 AM EDT - 2 months ago

Nuwellis Completes Acquisition of Rendiatech

Mar 10, 2026, 9:00 AM EDT - 2 months ago

Nuwellis Earnings Call Transcript: Q4 2025

2026-03-10T12:21:07.000Z - 2 months ago

Nuwellis reports Q4 EPS ($1.50) vs ($18.30) last year

Mar 10, 2026, 8:15 AM EDT - 2 months ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

2026-03-05T13:26:40.000Z - 2 months ago

Nuwellis appoints Goldstein as Director of Clinical Strategy

Mar 5, 2026, 8:00 AM EST - 2 months ago

Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

2026-02-26T13:12:57.000Z - 2 months ago

Nuwellis appoints McDonald, Emerson to board of directors

Feb 26, 2026, 8:00 AM EST - 2 months ago

Nuwellis Appoints David A. McDonald and Martin J.

Feb 24, 2026, 8:00 AM EST - 2 months ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

2026-02-04T11:11:26.000Z - 3 months ago

Nuwellis files to sell 4.28M shares of common stock for holders

2026-01-30T13:25:28.000Z - 3 months ago

Nuwellis appoints Schultz as Chief Financial Officer

Jan 30, 2026, 8:00 AM EST - 3 months ago

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

2026-01-29T21:45:37.000Z - 3 months ago

Nuwellis announces $5M private placement, warrant inducement transaction

2026-01-29T21:40:34.000Z - 3 months ago

Nuwellis to acquire Rendiatech, terms not disclosed

Jan 29, 2026, 4:36 PM EST - 3 months ago

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

Jan 29, 2026, 4:35 PM EST - 3 months ago

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

2026-01-27T14:00:45.000Z - 3 months ago

Here’s Why Nuwellis Stock (NUWE) Rocketed Today

Jan 23, 2026, 4:40 PM EST - 3 months ago

Nuwellis Announces Changes to Board of Directors

2026-01-06T13:36:04.000Z - 4 months ago

Nuwellis announces issuance of new U.S. patent on extracorporeal therapy

Jan 6, 2026, 8:15 AM EST - 4 months ago

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

2025-12-09T13:21:02.000Z - 5 months ago

Nuwellis announces presentation of data on broad utility of Aquadex

Dec 9, 2025, 8:15 AM EST - 5 months ago

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

2025-12-04T13:20:16.000Z - 5 months ago

Nuwellis says U.S. children’s hospital initiates Aquadex Ultrafiltration Program

Dec 4, 2025, 8:15 AM EST - 5 months ago

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Nov 12, 2025, 9:00 AM EST - 6 months ago

Nuwellis Earnings Call Transcript: Q3 2025

2025-11-12T13:21:08.000Z - 6 months ago

Nuwellis reports Q3 EPS 56c

Nov 12, 2025, 8:15 AM EST - 6 months ago

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

2025-11-10T14:11:39.000Z - 6 months ago

Nuwellis receives notice of allowance for U.S. patent on Vivian system

Nov 10, 2025, 9:00 AM EST - 6 months ago

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Oct 23, 2025, 9:00 AM EDT - 7 months ago

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

2025-09-30T12:55:15.000Z - 8 months ago

Nuwellis reports 92% survival in children with AKI in ULTRA-Peds registry

Sep 30, 2025, 8:45 AM EDT - 8 months ago

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

2025-09-18T13:05:23.000Z - 8 months ago

Nuwellis receives new U.S. patent reinforcing Vivian pediatric device

Sep 18, 2025, 9:00 AM EDT - 8 months ago

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Sep 17, 2025, 10:16 AM EDT - 8 months ago

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Sep 9, 2025, 9:00 AM EDT - 8 months ago

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Sep 4, 2025, 8:15 AM EDT - 8 months ago

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Aug 21, 2025, 8:15 AM EDT - 9 months ago

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Aug 19, 2025, 8:15 AM EDT - 9 months ago

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Aug 15, 2025, 8:15 AM EDT - 9 months ago

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 14, 2025, 9:00 AM EDT - 9 months ago

Nuwellis Earnings Call Transcript: Q2 2025

Aug 14, 2025, 8:15 AM EDT - 9 months ago

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 7, 2025, 8:15 AM EDT - 9 months ago

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Aug 6, 2025, 8:15 AM EDT - 9 months ago

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Aug 5, 2025, 8:15 AM EDT - 10 months ago

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Aug 4, 2025, 5:24 PM EDT - 10 months ago

Nuwellis Stockholders Approve All Proposals at Special Meeting

Jul 23, 2025, 8:45 AM EDT - 10 months ago

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 23, 2025, 8:15 AM EDT - 10 months ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Jul 22, 2025, 8:15 AM EDT - 10 months ago

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 17, 2025, 7:35 AM EDT - 10 months ago

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Jul 15, 2025, 4:05 PM EDT - 10 months ago

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Jul 2, 2025, 8:15 AM EDT - 11 months ago

Nuwellis Appoints John Erb as Chief Executive Officer

Jun 10, 2025, 4:15 PM EDT - 1 year ago

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Jun 9, 2025, 9:15 AM EDT - 1 year ago

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

May 13, 2025, 9:00 AM EDT - 1 year ago

Nuwellis Earnings Call Transcript: Q1 2025

May 13, 2025, 7:00 AM EDT - 1 year ago

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 12, 2025, 7:00 AM EDT - 1 year ago

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 8, 2025, 7:00 AM EDT - 1 year ago

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

Apr 24, 2025, 7:00 AM EDT - 1 year ago

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

bazooka007 May. 13 at 7:01 AM

$NUWE a so/so q1 er. Still confident in their portfolio. We will see.

0 · Reply

ImfatTrader16 May. 12 at 11:39 PM

0 · Reply

Felixii May. 12 at 8:08 PM

$NUWE

0 · Reply

done84 May. 12 at 5:10 PM

$NUWE Dilutiom machine. Out of cash again. Scam company. Rot in hell! 🖕🖕

0 · Reply

bazooka007 May. 12 at 1:53 PM

$NUWE please not too much price action

0 · Reply

Dominicstocks May. 12 at 1:38 PM

$NUWE

0 · Reply

EarningsInsider May. 12 at 1:30 PM

https://www.marketbeat.com/earnings/reports/2026-5-12-nuwellis-inc-stock/ $NUWE Nuwellis Earnings Transcript

0 · Reply

StocktwitsEarnings May. 12 at 1:22 PM

0 · Reply

The_Gambl3r May. 12 at 1:00 PM

$NUWE ..

0 · Reply

done84 May. 12 at 9:56 AM

$NUWE Scam 🖕🖕

0 · Reply

Parobolicbatman May. 11 at 9:26 PM

$NUWE how we feeling for earnings

0 · Reply

The_Gambl3r May. 11 at 8:04 PM

$NUWE

0 · Reply

boredandstroked May. 11 at 7:45 PM

$NUWE Er tomorrow

0 · Reply

Felixii May. 11 at 7:27 PM

$NUWE

0 · Reply

TheRipple May. 11 at 4:51 PM

$NUWE Cmahn Baby..

0 · Reply

TheRipple May. 8 at 3:33 AM

$NUWE

0 · Reply

Intuitive_Investing May. 7 at 2:05 PM

$NUWE Short Squeeze triggered

2 · Reply

bazooka007 May. 7 at 7:58 AM

$NUWE 12th of May Q1/26 earnings report

0 · Reply

The_Gambl3r May. 7 at 3:09 AM

$LIVN $MDT $FMS $BAX $NUWE ** 👀👀

1 · Reply

The_Gambl3r May. 7 at 2:13 AM

$NUWE Catalyst Much?.. precision fluid removal…

0 · Reply

Dominicstocks May. 6 at 7:38 PM

$NUWE

0 · Reply

done84 May. 6 at 6:13 PM

$NUWE Don't fall for the empty stupid pumping. They have been doing this since $40. Stay away from this toxic worthless company!

0 · Reply

Market Cap	2.56M
Revenue (ttm)	8.27M
Net Income (ttm)	-17.52M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-211.85%
Debt to Equity Ratio	0.00

Volume	45,900
Avg Vol	60,748
Day's Range	N/A - N/A
Shares Out	2.46M
Stochastic %K	17%
Beta	0.25
Analysts	Hold
Price Target	$11.00